Correlation Engine 2.0
Clear Search sequence regions

  • breast tumors (1)
  • cancer (2)
  • colon cancer (1)
  • colon tumors (1)
  • humans (1)
  • LOX 1 (10)
  • lung tumors (1)
  • macrophages (1)
  • metastasis (2)
  • mice (2)
  • MMP 2 (1)
  • MMP 9 (1)
  • NF kB (1)
  • osteosarcoma (1)
  • ox ldl (1)
  • prostate (1)
  • receptor (3)
  • receptors e (2)
  • tumor metastasis (1)
  • vegf (2)
  • β catenin (1)
  • Sizes of these terms reflect their relevance to your search.

    Recently, a strong correlation between metabolic disorders, tumor onset, and progression has been demonstrated, directing new therapeutic strategies on metabolic targets. OLR1 gene encodes the LOX-1 receptor protein, responsible for the recognition, binding, and internalization of ox-LDL. In the past, several studied, aimed to clarify the role of LOX-1 receptor in atherosclerosis, shed light on its role in the stimulation of the expression of adhesion molecules, pro-inflammatory signaling pathways, and pro-angiogenic proteins, including NF-kB and VEGF, in vascular endothelial cells and macrophages. In recent years, LOX-1 upregulation in different tumors evidenced its involvement in cancer onset, progression and metastasis. In this review, we outline the role of LOX-1 in tumor spreading and metastasis, evidencing its function in VEGF induction, HIF-1alpha activation, and MMP-9/MMP-2 expression, pushing up the neoangiogenic and the epithelial-mesenchymal transition process in glioblastoma, osteosarcoma prostate, colon, breast, lung, and pancreatic tumors. Moreover, our studies contributed to evidence its role in interacting with WNT/APC/β-catenin axis, highlighting new pathways in sporadic colon cancer onset. The application of volatilome analysis in high expressing LOX-1 tumor-bearing mice correlates with the tumor evolution, suggesting a closed link between LOX-1 upregulation and metabolic changes in individual volatile compounds and thus providing a viable method for a simple, non-invasive alternative monitoring of tumor progression. These findings underline the role of LOX-1 as regulator of tumor progression, migration, invasion, metastasis formation, and tumor-related neo-angiogenesis, proposing this receptor as a promising therapeutic target and thus enhancing current antineoplastic strategies. © 2021. The Author(s).


    M Murdocca, C De Masi, S Pucci, R Mango, G Novelli, C Di Natale, F Sangiuolo. LOX-1 and cancer: an indissoluble liaison. Cancer gene therapy. 2021 Nov;28(10-11):1088-1098

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 33402733

    View Full Text